SIS
JAZZ icon

Strategic Investment Solutions’s Jazz Pharmaceuticals JAZZ Stock Holding History

Strategic Investment Solutions’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4
Closed -$446 – 672
2024
Q3 		$446 Buy
+4
New +$438 ﹤0.01% 575
2023
Q4 		$492 Sell
4
-248
-98% -$30.9K ﹤0.01% 1051
2023
Q3 		$33.6K Buy
252
+248
+6,200% +$33K ﹤0.01% 622
2023
Q2 		$516 Hold
4
– – ﹤0.01% 810
2023
Q1 		$585 Buy
+4
New +$592 ﹤0.01% 946

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Strategic Investment Solutions's JAZZ Position: Q4 2024 in Review

Strategic Investment Solutions sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2024, closing a stake of 4 shares — an estimated $446 sold.

Strategic Investment Solutions first reported a position in JAZZ in Q1 2023 and held it in 5 quarters. The position peaked at $33.6K in Q3 2023. 508 funds tracked by Wall St. Rank hold JAZZ as of Q4 2024.

  • Strategic Investment Solutions reported no remaining Jazz Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Strategic Investment Solutions sold 4 Jazz Pharmaceuticals shares in Q4 2024, an estimated $446.
  • Strategic Investment Solutions first reported a position in Jazz Pharmaceuticals in Q1 2023 and held it in 5 quarters.
  • Strategic Investment Solutions's Jazz Pharmaceuticals position peaked at $33.6K in Q3 2023.
  • 508 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2024.

Based on Strategic Investment Solutions's 13F filing for Q4 2024, filed 13 Feb 2025.